Smith & Nephew plc (SNN)
 NYSE: SNN · Real-Time Price · USD
 36.77
 -0.05 (-0.14%)
  At close: Nov 3, 2025, 4:00 PM EST
36.77
 0.00 (0.00%)
  After-hours: Nov 3, 2025, 7:00 PM EST
Smith & Nephew Market Cap
Smith & Nephew has a market cap or net worth of $15.56 billion as of November 3, 2025. Its market cap has increased by 22.83% in one year.
Market Cap 
 15.56B
Enterprise Value 
 18.22B
1-Year Change 
 22.83%
Ranking 
 Category 
 Stock Price 
$36.77
Market Cap Chart
Since October 15, 2002, Smith & Nephew's market cap has increased from $5.44B to $15.56B, an increase of 186.08%. That is a compound annual growth rate of 4.66%.
Market Cap History
| Date | Market Cap | % Change | 
|---|---|---|
| Oct 31, 2025 | 16.16B | 49.80% | 
| Dec 31, 2024 | 10.79B | -9.89% | 
| Dec 29, 2023 | 11.97B | 0.59% | 
| Dec 30, 2022 | 11.90B | -22.30% | 
| Dec 31, 2021 | 15.32B | -17.93% | 
| Dec 31, 2020 | 18.66B | -12.54% | 
| Dec 31, 2019 | 21.34B | 28.18% | 
| Dec 31, 2018 | 16.65B | 5.25% | 
| Dec 29, 2017 | 15.82B | 14.90% | 
| Dec 30, 2016 | 13.77B | -18.67% | 
| Dec 31, 2015 | 16.93B | 0.36% | 
| Dec 31, 2014 | 16.87B | 22.00% | 
| Dec 31, 2013 | 13.83B | 31.20% | 
| Dec 31, 2012 | 10.54B | 15.06% | 
| Dec 30, 2011 | 9.16B | -8.37% | 
| Dec 31, 2010 | 10.00B | 2.66% | 
| Dec 31, 2009 | 9.74B | 59.07% | 
| Dec 31, 2008 | 6.12B | -43.51% | 
| Dec 31, 2007 | 10.84B | 10.06% | 
| Dec 29, 2006 | 9.84B | 81.20% | 
| Dec 31, 2002 | 5.43B | -0.08% | 
| Oct 15, 2002 | 5.44B | - | 
View and export this data all the way back to 2002. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
 Full DefinitionRelated Stocks
| Company | Market Cap | 
|---|---|
| Eli Lilly and Company | 772.59B | 
| Johnson & Johnson | 455.04B | 
| AbbVie | 385.18B | 
| UnitedHealth Group | 309.40B | 
| AstraZeneca | 253.98B | 
| Novartis AG | 237.13B | 
| Novo Nordisk | 216.87B | 
| Abbott Laboratories | 214.96B |